Rifabutin: A Repurposing Candidate for Mycobacterium abscessus Lung Disease

Rifabutin: A Repurposing Candidate for Mycobacterium abscessus Lung Disease

Bibliographic Details
Main Author:	Thomas Dick
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2020-02-01
Series:	Frontiers in Microbiology
Subjects:	rifabutin Mycobacterium repurposing lung disease erm41
Online Access:	https://www.frontiersin.org/article/10.3389/fmicb.2020.00371/full

Similar Items

Rifabutin Suppresses Inducible Clarithromycin Resistance in <i>Mycobacterium abscessus</i> by Blocking Induction of <i>whiB7</i> and <i>erm41</i>
by: Dinah Binte Aziz, et al.
Published: (2020-02-01)

A real-time PCR assay for rapid identification of inducible and acquired clarithromycin resistance in Mycobacterium abscessus
by: Meenu Kaushal Sharma, et al.
Published: (2020-12-01)

Teicoplanin – Tigecycline Combination Shows Synergy Against Mycobacterium abscessus
by: Dinah B. Aziz, et al.
Published: (2018-05-01)

Comparison of Rifabutin-Based Versus Rifampin-Based Regimens for the Treatment of Mycobacterium avium Complex: A meta-Analysis Study
by: Bahareh Hajikhani, et al.
Published: (2021-09-01)

Development of a loop-mediated isothermal amplification coupled lateral flow dipstick targeting erm(41) for detection of Mycobacterium abscessus and Mycobacterium massiliense
by: Dongxin Liu, et al.
Published: (2019-01-01)

Mycobacterium abscessus subsp. abscessus Lung Disease: Drug Susceptibility Testing in Sputum Culture Negative Conversion
by: Takehiko Kobayashi, et al.
Published: (2018-01-01)

Therapeutic implications of nano-encapsulated rifabutin, azithromycin & ethambutol against experimental Mycobacterium avium infection in mice
by: Tapinder Kaur Grewal, et al.
Published: (2018-01-01)

Antimicrobial Susceptibility of Mycobacterium abscessus Complex Clinical Isolates from a Chinese Tertiary Hospital
by: Guo Y, et al.
Published: (2020-06-01)

Correlation of rpoB mutations with minimal inhibitory concentration of Rifampin and Rifabutin in Mycobacterium tuberculosis in an HIV/AIDS endemic setting, South Africa
by: Ivy - Rukasha, et al.
Published: (2016-12-01)

Rifabutin Resistance Associated with Double Mutations in rpoB Gene in Mycobacterium tuberculosis Isolates
by: Wei Jing, et al.
Published: (2017-09-01)

Commentary: Rifabutin Resistance Associated with Double Mutations in rpoB Gene in Mycobacterium tuberculosis Isolates
by: Sandeep Sharma, et al.
Published: (2017-11-01)

Rifabutin corneal deposits localized to the deep stroma using anterior segment optical coherence tomography
by: Tianyi Zhang, et al.
Published: (2020-06-01)

Tuberculosis-HIV treatment with rifampicin or rifabutin: are the outcomes different?
by: Carolina Arana Stanis Schmaltz, et al.
Published: (2019-02-01)

Spherical amorphous nanoparticles loading with antituberculosis substance rifabutin
by: A. P. Kaplun, et al.
Published: (2010-04-01)

Treatment for Mycobacterium abscessus complex–lung disease
by: Ya-Wei Weng, et al.
Published: (2020-06-01)

Tenofovir alafenamide and rifabutin co-administration does not lead to loss of HIV-1 suppression: A retrospective observational study
by: Thomas C.S. Martin, et al.
Published: (2020-11-01)

Rifabutin-based Fourth and Fifth-line Rescue Therapy in Patients with for Helicobacter pylori Eradication Failure
by: Jihee Sung, et al.
Published: (2017-02-01)

Rifabutin-Cobicistat Drug Interaction Resulting in Severe Bilateral Panuveitis
by: Christopher B. Toomey, et al.
Published: (2020-04-01)

The Contribution of Efflux Pumps in <i>Mycobacterium abscessus</i> Complex Resistance to Clarithromycin
by: Júlia S. Vianna, et al.
Published: (2019-09-01)

Perfil molecular e de suscetibilidade a claritromicina do complexo Mycobacterium abscessus
by: Carneiro, Maiara dos Santos
Published: (2016)

Perfil molecular e de suscetibilidade a claritromicina do complexo Mycobacterium abscessus
by: Carneiro, Maiara dos Santos
Published: (2016)

Perfil molecular e de suscetibilidade a claritromicina do complexo Mycobacterium abscessus
by: Carneiro, Maiara dos Santos
Published: (2016)

Mycobacterioses Induced by Mycobacterium abscessus: Case Studies Indicating the Importance of Molecular Analysis for the Identification of Antibiotic Resistance
by: Bolehovska, R., et al.
Published: (2022)

Rifabutin-Loaded Nanostructured Lipid Carriers as a Tool in Oral Anti-Mycobacterial Treatment of Crohn’s Disease
by: Helena Rouco, et al.
Published: (2020-10-01)

Rifabutin Use in <i>Staphylococcus</i> Biofilm Infections: A Case Series
by: James B. Doub, et al.
Published: (2020-06-01)

Rifabutin for the Treatment of <i>Helicobacter Pylori</i> Infection: A Review
by: Javier P. Gisbert
Published: (2021-12-01)

Lack of association between rrl and erm(41) mutations and clarithromycin resistance in Mycobacterium abscessus complex
by: Maiara dos Santos Carneiro, et al.

Molecular docking analysis and antidiabetic activity of Rifabutin against STZ-NA induced diabetes in albino wistar rats
by: Danish Ahmed, et al.
Published: (2017-09-01)

Mixed Infection of Mycobacterium abscessus subsp. abscessus and Mycobacterium tuberculosis in the Lung
by: Sungmin Sohn, et al.
Published: (2017-02-01)

Pharmacokinetic study of two different rifabutin doses co-administered with lopinavir/ritonavir in African HIV and tuberculosis co-infected adult patients
by: Seni Kouanda, et al.
Published: (2020-06-01)

Otomastoiditis Caused by Mycobacterium abscessus, the Netherlands
by: Jakko van Ingen, et al.
Published: (2010-01-01)

Pharmacokinetics of plasma lopinavir and ritonavir in tuberculosis–HIV co-infected African adult patients also receiving rifabutin 150 or 300 mg three times per week
by: Henri Gautier Ouedraogo, et al.
Published: (2020-01-01)

The efficacy and safety of a therapy regimen including raltegravir and a fixed dose combination of lamivudine and abacavir in previously rifabutin-treated patients with tuberculosis and HIV infection
by: A V Kravchenko, et al.
Published: (2014-11-01)

The Antimalarial Mefloquine Shows Activity against <i>Mycobacterium abscessus</i>, Inhibiting Mycolic Acid Metabolism
by: Giulia Degiacomi, et al.
Published: (2021-08-01)

Novel Treatments against <i>Mycobacterium tuberculosis</i> Based on Drug Repurposing
by: Álvaro Mourenza, et al.
Published: (2020-08-01)

Hypercalcaemia secondary to disseminated Mycobacterium abscessus and Mycobacterium fortuitum
by: Navin, et al.
Published: (2019-09-01)

Rifabutin-Containing Triple Therapy (RHB-105) for Eradication of <i>Helicobacter pylori</i>: Randomized ERADICATE Hp Trial
by: Ira N. Kalfus, et al.
Published: (2020-10-01)

A drug repurposing study based on clinical big data for the treatment of interstitial lung disease
by: SONI, SISWANTO
Published: (2020)

Rifabutin-Based Rescue Therapy for <i>Helicobacter pylori</i> Eradication: A Long-Term Prospective Study in a Large Cohort of Difficult-to-Treat Patients
by: Davide Giuseppe Ribaldone, et al.
Published: (2019-02-01)

<it>Mycobacterium abscessus</it> multispacer sequence typing
by: Sassi Mohamed, et al.
Published: (2013-01-01)